Automation
IT & Software

IT & Software News

View news from other Pharmaceutical sectors:
46-60 of 1781 results
PeptiDream licenses PDPS technology to Genentech
PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS) technology.
Automation > IT & Software > News
Hanmi Pharmaceutical expands technology partnership with Medidata
By PBR Staff Writer
South-Korea based Hanmi Pharmaceutical is expanding its technology partnership with Medidata, which provides cloud-based solutions for clinical research.
Automation > IT & Software > News
Pfizer selects Oracle Cloud for clinical data management and trial management
Pfizer has selected Oracle Cloud for clinical data management and trial management across its clinical trial portfolio.
Automation > IT & Software > News
Rgenix announces $33m series B financing to develop cancer therapeutics
Rgenix, a cancer therapeutics company developing first-in-class drugs targeting novel cancer pathways, announced a $33m Series B financing led by Novo A/S and Sofinnova Partners, with participation from existing investors including Partnership Fund for New York City, Alexandria Venture Investments, and Conegliano Ventures LP.
Automation > IT & Software > News
Alpine Immune Sciences raises $48m to develop next generation immunotherapies
Alpine Immune Sciences (AIS), a privately held biotechnology company developing a next-generation immune system modulation platform, has closed its $48m Series A financing round.
Automation > IT & Software > News
Virtual reality smartphone app provides glimpse into life with dementia
An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June.
Automation > IT & Software > News
Kalytera Therapeutics licenses Transdermal drug delivery technology from Delivra
Delivra has entered into a technology licensing agreement with Kalytera Therapeutics.
Automation > IT & Software > News
Integral Molecular develops B-Cell cloning technology to discover rare antibodies against membrane proteins
Integral Molecular has developed an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune cells (B-cells), enabling deep mining of entire immune repertoires to discover rare and diverse monoclonal antibodies for therapeutic purposes.
Automation > IT & Software > News
JHL Biotech selects PaizaBio to provide fill-finish services for multiple projects
PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects.
Automation > IT & Software > News
Bayer, ERS Genomics sign licensing deal for genome editing patents
Bayer and ERS have signed a patent license agreement whereby Bayer gains access to ERS' CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer's core strategic areas.
Automation > IT & Software > News
IBM Research and Singapore’s Bioengineering Institute develop anti-viral technology
By PBR Staff Writer
IBM Research and Singapore’s Institute of Bioengineering and Nanotechnology have discovered a new macromolecule with triple-play action to help fight virus infection and drug resistance.
Automation > IT & Software > News
UCLA scientists use gene-editing technology for faster antiviral drug development
In an advance that could lead to the development of better treatments for viral pathogens, such as Zika, a team of scientists at the California NanoSystems Institute at UCLA are developing a more accurate and more cost-effective DNA-screening system based on gene-editing technology.
Automation > IT & Software > News
IBC Generium selects Goodwin Biotechnology to optimize process of IgG-based bispecific antibody
International Biotechnology Center "Generium", (LLC IBC Generium), has selected Goodwin Biotechnology for the assay and process technology transfer, process scale-up, and cGMP manufacturing of an IgG-based, bispecific antibody to support early stage clinical trials.
Automation > IT & Software > News
biOasis Technologies signs license deal with Astellas Research Institute of America
biOasis Technologies has entered into a License Agreement to collaborate with Astellas Research Institute of America (Astellas).
Automation > IT & Software > News
Bristol-Myers Squibb selects Medidata Clinical Cloud to help manage clinical trials
Bristol-Myers Squibb has selected the Medidata Clinical Cloud to help manage, monitor and analyze its clinical trials.
Automation > IT & Software > News
46-60 of 1781 results